IRIS
MURA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 790
EU - Europa 647
AS - Asia 437
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 782
CN - Cina 433
IE - Irlanda 186
UA - Ucraina 143
FI - Finlandia 102
DE - Germania 79
SE - Svezia 43
IT - Italia 34
GB - Regno Unito 23
FR - Francia 20
BE - Belgio 11
CA - Canada 8
NL - Olanda 4
AU - Australia 3
EU - Europa 2
IN - India 2
MU - Mauritius 2
RU - Federazione Russa 2
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.882
Salva come PNG Salva come JPEG
Città #
Chandler 191
Dublin 186
Jacksonville 163
Nanjing 136
Ann Arbor 55
Ashburn 53
Beijing 53
Nanchang 47
Helsinki 38
Changsha 34
Hebei 34
Princeton 33
Shenyang 33
Lawrence 32
Jiaxing 29
Wilmington 29
Hangzhou 19
Medford 18
Boardman 17
Tianjin 14
Pavia 12
Woodbridge 12
Brussels 11
Milan 11
Norwalk 10
Toronto 8
Shanghai 7
Kunming 6
Fairfield 5
Verona 5
New York 4
Washington 4
Phoenix 3
Taizhou 3
Zhengzhou 3
Falls Church 2
Houston 2
Philadelphia 2
Shirley 2
Vercelli 2
Adelaide 1
Amsterdam 1
Bangalore 1
Berlin 1
Bloomfield 1
Canberra 1
Changchun 1
Dunedin 1
Falkenstein 1
Guangzhou 1
Harbin 1
Hefei 1
Jinan 1
Lanzhou 1
Los Angeles 1
Manchester 1
Mozzate 1
Ningbo 1
Reston 1
Riyadh 1
Rockville 1
Sydney 1
Taiyuan 1
Tappahannock 1
Totale 1.352
Salva come PNG Salva come JPEG
Nome #
1 Brain area-selective neuromodulatory action of beta-amyloid 85
Intrathecal baclofen in patients with persistent vegetative state: 2 hypotheses 85
La fibromialgia: basi biologiche e aspetti di farmacoterapia 80
Innovazione e terapia della malattia di Alzheimer: il punto di vista farmacologico 80
Brain area-selective neuromodulatory action of beta-amyloid 79
Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes. 79
Oxycodone pain management in cytochrome p450-impaired patients. 74
Appreciation of functional rather than lesional effects of beta amyloid (AB): a study on dopamine release following in vivo AB infusion 69
Different Effects of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Aminoacids in Rat Hippocampus 62
Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? 61
Neuromodulatory actions of beta-amyloid 1-40 on the muscarinic receptors modulating the release of ACh, GABA and DA from isolated nerve endings in the rat nucleus accumbens 60
Beta amyloid neuromodulatory activities: a challenge to beta amyloid targeting in Alzheimer's disease 60
Awakenings and awareness recovery in disorders of consciousness is there a role for drugs? 59
Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus. 59
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 58
Specific neuromodulatory actions of beta-amyloid on dopamine release in rat nucleus accumbens and caudate putamen 57
Alternative views on beta amyloid: a disease target or a cell neuromodulator at the edge between signalling and degeneration. 57
Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution 57
Studio dei fattori di rischio genetico nella malattia di Alzheimer: il contributo del gene codificante il recettore α (ESR1) degli estrogeni. 54
Amyloid modulation of neurotransmission at synaptic level 54
β-amyloid modulates the function of nAChRs which stimulate, in vivo and in vitro, the release of glutamate, aspartate and GABA in rat hippocampus 52
Specific inhibitory effect of beta-amyloid on presynaptic muscarinic receptor subtypes modulating neurotranmitter release in the rat nucleus accumbens 51
Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens 51
Neuromodulatory actions of beta-amyloid on the DA release. 49
β-amyloid impairs the nicotinic-stimulated neurotransmitter release in rat hippocampus in absence of neurotoxicity 49
Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus 49
Stimulus-selective neuromodulatory action of beta-amyloid 47
Selective neuromodulatory action of beta-amyloid in different brain areas 47
Effect of beta-amyloid in vivo infusion on dopamine release in absence of lesional effects 44
β-amyloid influences nicotinic-stimulated release of both excitatory and inhibitory neurotransmitters in rat hippocampus 42
null 39
Pharmacological modulation of the state of awareness in patients with disorders of consciousness: an overview 29
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus. 22
Totale 1.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 2 1 6
2019/2020529 135 205 1 30 0 33 8 30 2 55 29 1
2020/2021258 34 25 7 29 3 41 3 38 5 34 34 5
2021/2022153 3 3 6 3 6 14 7 13 8 2 22 66
2022/2023527 62 40 4 36 58 61 0 30 212 1 14 9
2023/2024161 34 32 9 13 25 32 6 4 2 4 0 0
Totale 1.900